title: Possible liver damage by biosynthetic human insulin.
authors.forename: H
authors.initials: H
authors.lastname: Shimizu
authors.forename: K I
authors.initials: KI
authors.lastname: Ohtani
authors.forename: T
authors.initials: T
authors.lastname: Kudoh
authors.forename: T
authors.initials: T
authors.lastname: Tsuchiya
authors.forename: H
authors.initials: H
authors.lastname: Takahashi
authors.forename: N
authors.initials: N
authors.lastname: Sato
authors.forename: T
authors.initials: T
authors.lastname: Iriuchijima
authors.forename: M
authors.initials: M
authors.lastname: Mori
mesh_terms: D056486:Chemical and Drug Induced Liver Injury; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004342:Drug Hypersensitivity; D006801:Humans; D007328:Insulin / Q000009:adverse effects* / Q000096:biosynthesis / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012441:Saccharomyces cerevisiae / Q000378:metabolism
chemical_list: D007328:Insulin